Brevan Howard Capital Management’s Pfizer PFE Stock Holding History

Brevan Howard Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Buy	49,400 +20,553	+71%	+$538K	0.01%	976
2026 Q1	$810K	Sell	28,847 -286,343	-91%	-$7.62M	0.01%	1025
2025 Q4	$7.85M	Sell	315,190 -21,272	-6%	-$536K	0.09%	146
2025 Q3	$8.57M	Sell	336,462 -10,614	-3%	-$262K	0.04%	136
2025 Q2	$8.41M	Sell	347,076 -2,085,422	-86%	-$48.6M	0.05%	225
2025 Q1	$61.6M	Buy	2,432,498 +2,210,077	+994%	+$57.8M	0.59%	14
2024 Q4	$5.9M	Buy	222,421 +139,109	+167%	+$3.77M	0.04%	123
2024 Q3	$2.41M	Buy	+83,312	New	+$2.43M	0.02%	238
2024 Q1	–	Sell	-43,091	Closed	-$1.24M	–	1275
2023 Q4	$1.24M	Buy	43,091 +16,422	+62%	+$496K	0.02%	191
2023 Q3	$885K	Buy	+26,669	New	+$943K	0.01%	101

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brevan Howard Capital Management's PFE Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Pfizer (PFE) stake by 71% in Q2 2026, buying an estimated $538K and bringing the position to 49,400 shares worth $1.19M. The position accounts for 0.01% of the portfolio, ranked #976.

Brevan Howard Capital Management first reported a position in PFE in Q3 2023 and has held it in 10 quarters since. The position peaked at $61.6M in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Brevan Howard Capital Management held 49,400 shares of Pfizer worth $1.19M as of Q2 2026.
Brevan Howard Capital Management bought 20,553 Pfizer shares in Q2 2026, an estimated $538K.
Pfizer made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #976 holding.
Brevan Howard Capital Management first reported a position in Pfizer in Q3 2023 and has held it in 10 quarters since.
Brevan Howard Capital Management's Pfizer position peaked at $61.6M in Q1 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.